Home › Bronchiolitis Obliterans Syndrome › Florida › Tampa
Bronchiolitis Obliterans Syndrome clinical trials in Tampa, FL
6 studies for Bronchiolitis Obliterans Syndrome are looking for participants at sites in and around Tampa (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
RecruitingPhase 2
- Moffitt Cancer Center, Tampa
Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
RecruitingPhase 2
- Moffitt Cancer Center, Tampa
Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
RecruitingPhase 2
- Moffitt Cancer Center, Tampa
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
RecruitingPhase 3
- Moffitt Cancer Center, Tampa
Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
Recruiting
- University of South Florida, Tampa
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RecruitingPhase 2
- Moffitt Cancer Center, Tampa
Bronchiolitis Obliterans Syndrome trials in other cities
- Boston, MA13 studies
- Seattle, WA11 studies
- Atlanta, GA10 studies
- New York City, NY9 studies
- Houston, TX8 studies
- Los Angeles, CA7 studies
- Miami, FL7 studies
- Durham, NC6 studies
- Baldwin Park, CA6 studies
- Philadelphia, PA6 studies
- Washington, DC6 studies
- San Francisco, CA5 studies
Other studies in Tampa
- Non-Small Cell Lung Cancer51 studies
- Breast Cancer43 studies
- Cancer (all types)39 studies
- Colorectal Cancer34 studies
- Acute Myeloid Leukemia29 studies
- Metastatic Cancer29 studies
- Lung Cancer29 studies
- Pancreatic Cancer26 studies
- Ovarian Cancer21 studies
- Melanoma19 studies
- Myelodysplastic Syndromes19 studies
- Prostate Cancer18 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.